Exact Sciences’ Cologuard is now included in the 2017 Healthcare Effectiveness Data and Information Set (HEDIS) quality measures for colorectal cancer screening, the organization announced recently.

“Cologuard’s inclusion in the preeminent quality measures and its standing as an A-graded service in a leading screening guideline are critical steps toward becoming a standard of care for colon cancer screening,” Exact Sciences CEO Kevin Conroy said in a statement. “Quality measures rate health care providers, systems and payers on metrics, including colon cancer screening compliance and patient satisfaction.

According to a release, Cologaurd’s inclusion in HEDIS will be on a three-year interval period.

Colorectal cancer screening compliance and patient satisfaction are two measures that are evaluated to generate an overall quality score.

More than 90 percent of America’s health plans measure quality based on HEDIS.